Vaccinex VCNX
$ 1.41
-61.37%
Quarterly report 2024-Q3
added 11-14-2024
Vaccinex Cash Flow 2011-2024 | VCNX
Annual Cash Flow Vaccinex
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-17.2 M | -19.1 M | -25.3 M | -28.6 M | -30.7 M | -25.3 M | -21.4 M | - | - | - | - | - | - |
Depreciation & Amortization |
119 K | 207 K | 169 K | 307 K | 249 K | 223 K | 206 K | - | - | - | - | - | - |
Accounts Payables |
2.04 M | 1.52 M | 1.06 M | 3.17 M | 3.21 M | 2.32 M | - | - | - | - | - | - | - |
Accounts Receivables |
961 K | 175 K | - | 157 K | 898 K | 639 K | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Vaccinex
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -4.63 M | - | - | - | -5.04 M | - | -14.5 M | -10.3 M | -5 M | - | -20.2 M | -14.1 M | -7.11 M | - | -22.3 M | -13 M | -7.51 M | - | -24.9 M | -14.4 M | -8.48 M | - | -25.3 M | -25.3 M | -25.3 M | - | -15.1 M | -10.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
24 K | 25 K | 27 K | - | 31 K | 30 K | 31 K | - | 67 K | 54 K | 41 K | - | 37 K | 35 K | 55 K | - | 74 K | 87 K | 75 K | - | 64 K | 57 K | 60 K | - | 54 K | 56 K | 56 K | - | 54 K | 50 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
4.86 M | 3.24 M | 2.33 M | 2.04 M | 4.22 M | 1.61 M | 1.09 M | 1.52 M | 494 K | 265 K | 589 K | 1.06 M | 957 K | 1.72 M | 3.25 M | 3.17 M | 3.17 M | 3.17 M | 3.17 M | 3.21 M | 3.21 M | 3.21 M | 3.21 M | 2.32 M | 2.32 M | 2.32 M | 2.32 M | 1.91 M | 1.91 M | 1.91 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
985 K | 1.04 M | 2.78 M | 961 K | 933 K | 11 K | - | 175 K | 50 K | - | - | - | 50 K | - | 8 K | 157 K | 157 K | 157 K | 157 K | 898 K | 898 K | 898 K | 898 K | 639 K | 639 K | 639 K | 639 K | 117 K | 117 K | 117 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency